ProShares Bitcoin ETF vs State Street SPDR S&P Biotech ETF — how do they compare? ProShares Bitcoin ETF trades at $8.66, while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| BITO | XBI | |
|---|---|---|
Sector | Crypto-linked | Broad Market / Factor |
52-Week High | $22.27 | $164.28 |
52-Week Low | $7.98 | $86.92 |
Trailing returns across standard periods
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →